提起上睑与否对托吡卡胺滴眼液的扩瞳效果影响不大。
Conclusion: it showed that tropicamide eyedrops has little influence on mydriasis whether uplifting eyelid of patients or not.
目的探讨复方托吡卡胺滴眼液对测量角膜厚度的影响。
Objective To investigate the effect of dilating eyedrop on measurement of thickness of cornea.
比较点扩瞳剂托吡卡胺滴眼液时提上睑与否对其扩瞳效果的影响。
Objective: to compare the mydriasis effect of lifting up eyelid superior or not as using tropicamide eyedrop.
目的比较盐酸环喷托酯、复方托吡卡胺与阿托品对儿童验光中睫状肌麻痹的效果。
Objective to compare the effects of cyclopentolate hydrochloride, compound tropicamide and atropine on cycloplegia in children.
结论采用新斯的明联合复方托吡卡胺是治疗青少年进行性近视患者的一种可靠方法。
Conclusion the application of neostigmine accompanied with tropicamide is a reliable therapy for treatment of the progressing myopia in adolescent.
两组点扩瞳剂托吡卡胺滴眼液后扩瞳效果无统计学意义（P >0 .0 5 ）。
Result: there is no difference on mydriasis in these groups by dripping tropicamide eyedrops(P<0.05).
目的：探讨复方托吡卡胺滴眼液(美多丽)对5 ~ 9岁弱视儿童进行散瞳验光的可行性。
AIM: To study feasibility in the 5-9 years old amblyopia children who were dilated the pupil with Mydrin-P for refraction.
目的：探讨复方托吡卡胺滴眼液(美多丽)对5 ~ 9岁弱视儿童进行散瞳验光的可行性。
AIM: To study feasibility in the 5-9 years old amblyopia children who were dilated the pupil with Mydrin-P for refraction.
应用推荐